|
Short Title: ASPIRE
Enrollment Status: Recruiting
NCT #: NCT06588686
Specialty Area: Pulmonology
Condition Studied: Idiopathic Pulmonary Fibrosis
Age Groups: Adult; Older Adult
Phase: II
To evaluate the efficacy of buloxibutid compared to placebo in participants with idiopathic pulmonary fibrosis as assessed by Forced Vital Capacity (FVC)
Location: Renown Health, Office of Clinical Research
Address:
Complete Study Details: https://clinicaltrials.gov/study/NCT06588686
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.
